Literature DB >> 25916225

Lack of utility of symptoms and signs at first presentation as predictors of inflammatory bowel disease in secondary care.

Alexander C Ford1, Paul Moayyedi2, Premysl Bercik2, David G Morgan3, Carolina Bolino2, Maria I Pintos-Sanchez2, Walter Reinisch2.   

Abstract

OBJECTIVES: There are few data concerning the utility of symptoms and signs at first presentation in predicting a diagnosis of ulcerative colitis (UC) or Crohn's disease (CD). We conducted a study to examine this issue in secondary care.
METHODS: We collected complete symptom, colonoscopy, and histology data prospectively from 1,981 consecutive adult patients with lower gastrointestinal symptoms at two hospitals in Hamilton, Ontario. Assessors were blinded to symptom status. The reference standard used to define the presence of UC or CD was according to accepted histological criteria. Patients without UC or CD served as controls. Sensitivity, specificity, and positive and negative likelihood ratios (LRs) were calculated for individual items from the clinical history, as well as combinations of these.
RESULTS: In identifying 302 patients with inflammatory bowel diseases (IBD), positive LRs for individual items ranged from 1.18 (incomplete emptying) to 2.30 (passage of stools more than four times per day at least most of the time) and negative LRs from 0.70 (bloody stools) to 0.96 (incomplete emptying). Combinations of items had a high specificity, but at the expense of sensitivity. Items that were independent predictors of IBD after logistic regression analysis were family history of IBD, younger age, passage of stools more than four times per day ≥75% of the time, urgency most of the time, and anemia.
CONCLUSIONS: Individual items from the clinical history are not helpful in predicting a diagnosis of UC or CD. However, this may be because some items lacked sufficient detail. Combinations of symptoms and computer models had a high specificity, but overall were only modestly useful diagnostically. Future studies should evaluate biological markers in combination with symptoms to improve accuracy.

Entities:  

Mesh:

Year:  2015        PMID: 25916225     DOI: 10.1038/ajg.2015.117

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  27 in total

1.  Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002-2006.

Authors:  Laszlo Lakatos; Lajos S Kiss; Gyula David; Tunde Pandur; Zsuzsanna Erdelyi; Gabor Mester; Mihaly Balogh; Istvan Szipocs; Csaba Molnar; Erzsebet Komaromi; Peter Laszlo Lakatos
Journal:  Inflamm Bowel Dis       Date:  2011-01-06       Impact factor: 5.325

2.  Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care.

Authors:  Alexander C Ford; Premysl Bercik; David G Morgan; Carolina Bolino; Maria Ines Pintos-Sanchez; Paul Moayyedi
Journal:  Gastroenterology       Date:  2013-08-28       Impact factor: 22.682

3.  Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.

Authors:  Jost Langhorst; Sigrid Elsenbruch; Julia Koelzer; Andreas Rueffer; Andreas Michalsen; Gustav J Dobos
Journal:  Am J Gastroenterol       Date:  2007-10-04       Impact factor: 10.864

4.  The usefulness of the likelihood ratio in the diagnosis of dyspepsia and gastroesophageal reflux disease.

Authors:  P Moayyedi; A T Axon
Journal:  Am J Gastroenterol       Date:  1999-11       Impact factor: 10.864

5.  Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival.

Authors:  E V Loftus; M D Silverstein; W J Sandborn; W J Tremaine; W S Harmsen; A R Zinsmeister
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

6.  Prodromal irritable bowel syndrome may be responsible for delays in diagnosis in patients presenting with unrecognized Crohn's disease and celiac disease, but not ulcerative colitis.

Authors:  S M Barratt; J S Leeds; K Robinson; A J Lobo; M E McAlindon; D S Sanders
Journal:  Dig Dis Sci       Date:  2011-06-22       Impact factor: 3.199

7.  Delayed diagnosis is influenced by the clinical pattern of Crohn's disease and affects treatment outcomes and quality of life in the long term: a cross-sectional study of 361 patients in Southern Italy.

Authors:  Gianluca Pellino; Guido Sciaudone; Francesco Selvaggi; Gabriele Riegler
Journal:  Eur J Gastroenterol Hepatol       Date:  2015-02       Impact factor: 2.566

8.  Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987.

Authors:  E Langholz; P Munkholm; O H Nielsen; S Kreiner; V Binder
Journal:  Scand J Gastroenterol       Date:  1991-12       Impact factor: 2.423

9.  Discriminating IBD from IBS: comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies.

Authors:  Alain M Schoepfer; Michael Trummler; Petra Seeholzer; Beatrice Seibold-Schmid; Frank Seibold
Journal:  Inflamm Bowel Dis       Date:  2008-01       Impact factor: 5.325

10.  Diagnostic delay in Crohn's disease is associated with a complicated disease course and increased operation rate.

Authors:  Alain M Schoepfer; Mohamed-Ali Dehlavi; Nicolas Fournier; Ekaterina Safroneeva; Alex Straumann; Valérie Pittet; Laurent Peyrin-Biroulet; Pierre Michetti; Gerhard Rogler; Stephan R Vavricka
Journal:  Am J Gastroenterol       Date:  2013-08-27       Impact factor: 10.864

View more
  4 in total

1.  Rational investigations in irritable bowel syndrome.

Authors:  Christopher J Black; Alexander C Ford
Journal:  Frontline Gastroenterol       Date:  2019-06-06

Review 2.  The role of killer-cell immunoglobulin-like receptor (KIR) genes in susceptibility to inflammatory bowel disease: systematic review and meta-analysis.

Authors:  Anwar Fathollahi; Saeed Aslani; Shayan Mostafaei; Nima Rezaei; Mahdi Mahmoudi
Journal:  Inflamm Res       Date:  2018-06-04       Impact factor: 4.575

Review 3.  Enhancing High Value Care in Gastroenterology Practice.

Authors:  Michael Camilleri; David A Katzka
Journal:  Clin Gastroenterol Hepatol       Date:  2016-05-20       Impact factor: 11.382

4.  Ulcerative Colitis: Disease Burden, Impact on Daily Life, and Reluctance to Consult Medical Professionals: Results from a Japanese Internet Survey.

Authors:  Toshifumi Hibi; Toyomi Ishibashi; Yuka Ikenoue; Ryoichi Yoshihara; Akiko Nihei; Taku Kobayashi
Journal:  Inflamm Intest Dis       Date:  2020-02-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.